市場調査レポート

商品コード

1442606

遠隔患者モニタリング (RPM) の世界市場の評価：製品別、用途別、エンドユーザー別、地域別、機会、予測（2017年～2031年）

Remote Patient Monitoring Market Assessment, By Product, By Application, By End-user, By Region, Opportunities and Forecast, 2017-2031F

出版日: 2024年03月04日 | 発行: Market Xcel - Markets and Data

| ページ情報: 英文 235 Pages | 納期: 3～5営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　詳細はお問い合わせください。

価格

PDF & Excel Printable (Single User License)

USD 4,500 705,420円

レポートPDFを1名の方がご利用頂けるライセンスです。レポートPDFのパスワード保護はありません。PDF内のテキスト等のコピー＆ペーストは可能です。印刷は無制限で可能です。Excelのデータがライセンスに含まれています。

PDF & Excel Printable (Corporate License)

USD 5,700 893,532円

レポートPDFを企業の１カ国の拠点のすべての方がご利用頂けるライセンスです。レポートPDFのパスワード保護はありません。PDF内のテキスト等のコピー＆ペーストは可能ですが、企業内部での利用に限定されます。ご利用に際しては、あらかじめ出版社の許諾を得る必要があります。詳細はお問合せください。印刷は可能です。Excelのデータがライセンスに含まれています。

PDF & Excel Printable (Custom Research License)

USD 8,200 1,285,432円

レポートPDFを企業の１カ国の拠点のすべての方がご利用頂けるライセンスです。レポートPDFのパスワード保護はありません。PDF内のテキスト等のコピー＆ペーストは可能です。印刷は無制限で可能です。Excelのデータがライセンスに含まれています。アナリストアワー100時間が含まれており、レポートのカスタマイズなどにご利用いただけます。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=156.76円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

世界の遠隔患者モニタリング (RPM) の市場規模は、予測期間中にCAGR 13.26％で成長し、2023年の95億3,000万米ドルから、2031年には258億米ドルに成長すると予測されています。

市場拡大の背景には、遠隔患者モニタリング (RPM) や遠隔医療に関連するさまざまなコスト上のメリットに対する認識の拡大と、市場のさまざまな主要企業によるRPMへの投資の増加があります。RPMシステムやデバイスは、多くの場合、退院後のケアが必要な患者や慢性疾患を患っている患者を支援するために使用されています。RPMソリューションを使用してリスクの高い患者の健康状態やバイタルを監視することで、組織は患者の診察の合間にデータを更新し、潜在的な健康問題を患者に通知することができます。RPM機器は患者との関わりを強化し、ケアを向上させ、患者が医療をより利用しやすくします。RPM機器やサービスの利用に関連するさまざまな利点に対する認識の向上から、複数の病院がこれらのシステムを導入しており、大きな成長促進要因となっています。

投資と戦略的提携の増加が市場成長を支える

患者の利便性を向上させ、患者のケアを改善するために、さまざまな病院やヘルスケアセンターがRPMシステムやソフトウェアへの投資を増やしていることも同市場の成長を後押ししています。2024年1月、BangaloreのApollo Hospital Seshadripuramは、LifeSignsというAIを搭載した健康モニタリング技術企業との提携を発表しました。この提携は、同病院にワイヤレスRPMシステムを提供することで、積極的な患者管理と精密医療を大きく前進させるものと期待されています。

慢性疾患と老年人口の増加が市場拡大を後押し

慢性疾患の管理においてRPMの導入がもたらすさまざまな利点に対する認識が高まっており、市場に有利な成長機会を示しています。さまざまなヘルスケアプロバイダーが、癌、糖尿病、心血管疾患、慢性肺疾患などの慢性疾患を患う患者のケアにRPMを活用しています。RPMによってヘルスケアプロバイダーは関連データを収集し、患者の健康状態を追跡し、有害事象を回避するために必要な介入を行うことができます。遠隔患者管理は、患者のバイタルを追跡し、患者やその介護者、医療提供者に必要な情報を警告することで、慢性疾患管理の貴重なツールとして機能します。例えば糖尿病の場合、RPMは患者の血糖値、身体活動、インスリン摂取量を追跡します。世界保健機関 (WHO) によると、2050年頃までに、糖尿病、心血管疾患、呼吸器疾患、癌などのさまざまな慢性疾患が、毎年9,000万人の死因の86%を占めるようになるといいます。RPM市場の需要は、このような慢性疾患の有病率の増加により増加しています。

当レポートでは、世界の遠隔患者モニタリング (RPM) の市場を調査し、市場の定義と概要、市場規模の推移・予測、各種区分・地域別の詳細分析、産業構造、市場成長への影響因子の分析、ケーススタディ、競合情勢、主要企業のプロファイルなどをまとめています。

市場規模・予測
製品別
- 特別モニター
- バイタルサインモニター
- ソフトウェア
- サービス
用途別
- 心血管疾患
- 体重管理・フィットネスモニタリング
- 睡眠障害
- 感染症
- 癌
- 脱水
- 高血圧
- その他
エンドユーザー別
- 外来患者
- 在宅医療
- 入院患者
- その他
地域別
- 北米
- 南米
- 欧州
- アジア太平洋
- 中東・アフリカ
企業別市場シェア

第5章世界の遠隔患者モニタリング (RPM) 市場の展望：地域別

北米
欧州
アジア太平洋
南米
中東・アフリカ

第6章市場マッピング

製品別
用途別
エンドユーザー別
地域別

第7章マクロ環境と産業構造

需要供給分析
輸出入分析
バリューチェーン分析
PESTEL分析
ポーターのファイブフォース分析

第8章市場力学

成長促進要因
成長抑制要因 (課題・抑制要因)

第9章法規制の枠組み・イノベーション

特許環境
規制承認
イノベーション・新興技術

第10章主要企業の情勢

市場リーダー上位5社の競合マトリックス
市場リーダー上位5社の市場収益分析
M&A・ジョイントベンチャー (該当する場合)
SWOT分析 (参入5社)
特許分析 (該当する場合)

第11章価格分析

第12章ケーススタディ

第13章主要企業の見通し

Abbott Laboratories
OMRON Corporation
Koninklijke Philips N.V.
F. Hoffmann-La Roche AG
GE Healthcare
Boston Scientific Corporation
Nihon Kohden Corporation
Johnson & Johnson
BIOTRINIK SE & Co.
MD Revolution

第14章戦略的提言

第15章当社について・免責事項

図表

List of Tables

Table 1. Pricing Analysis of Products from Key Players
Table 2. Competition Matrix of Top 5 Market Leaders
Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

Figure 1. Global Remote Patient Monitoring Market, By Value, in USD Billion, 2017-2031F
Figure 2. Global Remote Patient Monitoring Market, By Volume, in Million Units, 2017-2031F
Figure 3. Global Remote Patient Monitoring Market Share (%), By Product, 2017-2031F
Figure 4. Global Remote Patient Monitoring Market Share (%), By Application, 2017-2031F
Figure 5. Global Remote Patient Monitoring Market Share (%), By End-user, 2017-2031F
Figure 6. Global Remote Patient Monitoring Market Share (%), By Region, 2017-2031F
Figure 7. North America Remote Patient Monitoring Market, By Value, in USD Billion, 2017-2031F
Figure 8. North America Remote Patient Monitoring Market, By Volume, in Million Units, 2017-2031F
Figure 9. North America Remote Patient Monitoring Market Share (%), By Product, 2017-2031F
Figure 10. North America Remote Patient Monitoring Market Share (%), By Application, 2017-2031F
Figure 11. North America Remote Patient Monitoring Market Share (%), By End-user, 2017-2031F
Figure 12. North America Remote Patient Monitoring Market Share (%), By Country, 2017-2031F
Figure 13. United States Remote Patient Monitoring Market, By Value, in USD Billion, 2017-2031F
Figure 14. United States Remote Patient Monitoring Market, By Volume, in Million Units, 2017-2031F
Figure 15. United States Remote Patient Monitoring Market Share (%), By Product, 2017-2031F
Figure 16. United States Remote Patient Monitoring Market Share (%), By Application, 2017-2031F
Figure 17. United States Remote Patient Monitoring Market Share (%), By End-user, 2017-2031F
Figure 18. Canada Remote Patient Monitoring Market, By Value, in USD Billion, 2017-2031F
Figure 19. Canada Remote Patient Monitoring Market, By Volume, in Million Units, 2017-2031F
Figure 20. Canada Remote Patient Monitoring Market Share (%), By Product, 2017-2031F
Figure 21. Canada Remote Patient Monitoring Market Share (%), By Application, 2017-2031F
Figure 22. Canada Remote Patient Monitoring Market Share (%), By End-user, 2017-2031F
Figure 23. Mexico Remote Patient Monitoring Market, By Value, in USD Billion, 2017-2031F
Figure 24. Mexico Remote Patient Monitoring Market, By Volume, in Million Units, 2017-2031F
Figure 25. Mexico Remote Patient Monitoring Market Share (%), By Product, 2017-2031F
Figure 26. Mexico Remote Patient Monitoring Market Share (%), By Application, 2017-2031F
Figure 27. Mexico Remote Patient Monitoring Market Share (%), By End-user, 2017-2031F
Figure 28. Europe Remote Patient Monitoring Market, By Value, in USD Billion, 2017-2031F
Figure 29. Europe Remote Patient Monitoring Market, By Volume, in Million Units, 2017-2031F
Figure 30. Europe Remote Patient Monitoring Market Share (%), By Product, 2017-2031F
Figure 31. Europe Remote Patient Monitoring Market Share (%), By Application, 2017-2031F
Figure 32. Europe Remote Patient Monitoring Market Share (%), By End-user, 2017-2031F
Figure 33. Europe Remote Patient Monitoring Market Share (%), By Country, 2017-2031F
Figure 34. Germany Remote Patient Monitoring Market, By Value, in USD Billion, 2017-2031F
Figure 35. Germany Remote Patient Monitoring Market, By Volume, in Million Units, 2017-2031F
Figure 36. Germany Remote Patient Monitoring Market Share (%), By Product, 2017-2031F
Figure 37. Germany Remote Patient Monitoring Market Share (%), By Application, 2017-2031F
Figure 38. Germany Remote Patient Monitoring Market Share (%), By End-user, 2017-2031F
Figure 39. France Remote Patient Monitoring Market, By Value, in USD Billion, 2017-2031F
Figure 40. France Remote Patient Monitoring Market, By Volume, in Million Units, 2017-2031F
Figure 41. France Remote Patient Monitoring Market Share (%), By Product, 2017-2031F
Figure 42. France Remote Patient Monitoring Market Share (%), By Application, 2017-2031F
Figure 43. France Remote Patient Monitoring Market Share (%), By End-user, 2017-2031F
Figure 44. Italy Remote Patient Monitoring Market, By Value, in USD Billion, 2017-2031F
Figure 45. Italy Remote Patient Monitoring Market, By Volume, in Million Units, 2017-2031F
Figure 46. Italy Remote Patient Monitoring Market Share (%), By Product, 2017-2031F
Figure 47. Italy Remote Patient Monitoring Market Share (%), By Application, 2017-2031F
Figure 48. Italy Remote Patient Monitoring Market Share (%), By End-user, 2017-2031F
Figure 49. United Kingdom Remote Patient Monitoring Market, By Value, in USD Billion, 2017-2031F
Figure 50. United Kingdom Remote Patient Monitoring Market, By Volume, in Million Units, 2017-2031F
Figure 51. United Kingdom Remote Patient Monitoring Market Share (%), By Product, 2017-2031F
Figure 52. United Kingdom Remote Patient Monitoring Market Share (%), By Application, 2017-2031F
Figure 53. United Kingdom Remote Patient Monitoring Market Share (%), By End-user, 2017-2031F
Figure 54. Russia Remote Patient Monitoring Market, By Value, in USD Billion, 2017-2031F
Figure 55. Russia Remote Patient Monitoring Market, By Volume, in Million Units, 2017-2031F
Figure 56. Russia Remote Patient Monitoring Market Share (%), By Product, 2017-2031F
Figure 57. Russia Remote Patient Monitoring Market Share (%), By Application, 2017-2031F
Figure 58. Russia Remote Patient Monitoring Market Share (%), By End-user, 2017-2031F
Figure 59. Netherlands Remote Patient Monitoring Market, By Value, in USD Billion, 2017-2031F
Figure 60. Netherlands Remote Patient Monitoring Market, By Volume, in Million Units, 2017-2031F
Figure 61. Netherlands Remote Patient Monitoring Market Share (%), By Product, 2017-2031F
Figure 62. Netherlands Remote Patient Monitoring Market Share (%), By Application, 2017-2031F
Figure 63. Netherlands Remote Patient Monitoring Market Share (%), By End-user, 2017-2031F
Figure 64. Spain Remote Patient Monitoring Market, By Value, in USD Billion, 2017-2031F
Figure 65. Spain Remote Patient Monitoring Market, By Volume, in Million Units, 2017-2031F
Figure 66. Spain Remote Patient Monitoring Market Share (%), By Product, 2017-2031F
Figure 67. Spain Remote Patient Monitoring Market Share (%), By Application, 2017-2031F
Figure 68. Spain Remote Patient Monitoring Market Share (%), By End-user, 2017-2031F
Figure 69. Turkey Remote Patient Monitoring Market, By Value, in USD Billion, 2017-2031F
Figure 70. Turkey Remote Patient Monitoring Market, By Volume, in Million Units, 2017-2031F
Figure 71. Turkey Remote Patient Monitoring Market Share (%), By Product, 2017-2031F
Figure 72. Turkey Remote Patient Monitoring Market Share (%), By Application, 2017-2031F
Figure 73. Turkey Remote Patient Monitoring Market Share (%), By End-user, 2017-2031F
Figure 74. Poland Remote Patient Monitoring Market, By Value, in USD Billion, 2017-2031F
Figure 75. Poland Remote Patient Monitoring Market, By Volume, in Million Units, 2017-2031F
Figure 76. Poland Remote Patient Monitoring Market Share (%), By Product, 2017-2031F
Figure 77. Poland Remote Patient Monitoring Market Share (%), By Application, 2017-2031F
Figure 78. Poland Remote Patient Monitoring Market Share (%), By End-user, 2017-2031F
Figure 79. South America Remote Patient Monitoring Market, By Value, in USD Billion, 2017-2031F
Figure 80. South America Remote Patient Monitoring Market, By Volume, in Million Units, 2017-2031F
Figure 81. South America Remote Patient Monitoring Market Share (%), By Product, 2017-2031F
Figure 82. South America Remote Patient Monitoring Market Share (%), By Application, 2017-2031F
Figure 83. South America Remote Patient Monitoring Market Share (%), By End-user, 2017-2031F
Figure 84. South America Remote Patient Monitoring Market Share (%), By Country, 2017-2031F
Figure 85. Brazil Remote Patient Monitoring Market, By Value, in USD Billion, 2017-2031F
Figure 86. Brazil Remote Patient Monitoring Market, By Volume, in Million Units, 2017-2031F
Figure 87. Brazil Remote Patient Monitoring Market Share (%), By Product, 2017-2031F
Figure 88. Brazil Remote Patient Monitoring Market Share (%), By Application, 2017-2031F
Figure 89. Brazil Remote Patient Monitoring Market Share (%), By End-user, 2017-2031F
Figure 90. Argentina Remote Patient Monitoring Market, By Value, in USD Billion, 2017-2031F
Figure 91. Argentina Remote Patient Monitoring Market, By Volume, in Million Units, 2017-2031F
Figure 92. Argentina Remote Patient Monitoring Market Share (%), By Product, 2017-2031F
Figure 93. Argentina Remote Patient Monitoring Market Share (%), By Application, 2017-2031F
Figure 94. Argentina Remote Patient Monitoring Market Share (%), By End-user, 2017-2031F
Figure 95. Asia-Pacific Remote Patient Monitoring Market, By Value, in USD Billion, 2017-2031F
Figure 96. Asia-Pacific Remote Patient Monitoring Market, By Volume, in Million Units, 2017-2031F
Figure 97. Asia-Pacific Remote Patient Monitoring Market Share (%), By Product, 2017-2031F
Figure 98. Asia-Pacific Remote Patient Monitoring Market Share (%), By Application, 2017-2031F
Figure 99. Asia-Pacific Remote Patient Monitoring Market Share (%), By End-user, 2017-2031F
Figure 100. Asia-Pacific Remote Patient Monitoring Market Share (%), By Country, 2017-2031F
Figure 101. India Remote Patient Monitoring Market, By Value, in USD Billion, 2017-2031F
Figure 102. India Remote Patient Monitoring Market, By Volume, in Million Units, 2017-2031F
Figure 103. India Remote Patient Monitoring Market Share (%), By Product, 2017-2031F
Figure 104. India Remote Patient Monitoring Market Share (%), By Application, 2017-2031F
Figure 105. India Remote Patient Monitoring Market Share (%), By End-user, 2017-2031F
Figure 106. China Remote Patient Monitoring Market, By Value, in USD Billion, 2017-2031F
Figure 107. China Remote Patient Monitoring Market, By Volume, in Million Units, 2017-2031F
Figure 108. China Remote Patient Monitoring Market Share (%), By Product, 2017-2031F
Figure 109. China Remote Patient Monitoring Market Share (%), By Application, 2017-2031F
Figure 110. China Remote Patient Monitoring Market Share (%), By End-user, 2017-2031F
Figure 111. Japan Remote Patient Monitoring Market, By Value, in USD Billion, 2017-2031F
Figure 112. Japan Remote Patient Monitoring Market, By Volume, in Million Units, 2017-2031F
Figure 113. Japan Remote Patient Monitoring Market Share (%), By Product, 2017-2031F
Figure 114. Japan Remote Patient Monitoring Market Share (%), By Application, 2017-2031F
Figure 115. Japan Remote Patient Monitoring Market Share (%), By End-user, 2017-2031F
Figure 116. Australia Remote Patient Monitoring Market, By Value, in USD Billion, 2017-2031F
Figure 117. Australia Remote Patient Monitoring Market, By Volume, in Million Units, 2017-2031F
Figure 118. Australia Remote Patient Monitoring Market Share (%), By Product, 2017-2031F
Figure 119. Australia Remote Patient Monitoring Market Share (%), By Application, 2017-2031F
Figure 120. Australia Remote Patient Monitoring Market Share (%), By End-user, 2017-2031F
Figure 121. Vietnam Remote Patient Monitoring Market, By Value, in USD Billion, 2017-2031F
Figure 122. Vietnam Remote Patient Monitoring Market, By Volume, in Million Units, 2017-2031F
Figure 123. Vietnam Remote Patient Monitoring Market Share (%), By Product, 2017-2031F
Figure 124. Vietnam Remote Patient Monitoring Market Share (%), By Application, 2017-2031F
Figure 125. Vietnam Remote Patient Monitoring Market Share (%), By End-user, 2017-2031F
Figure 126. South Korea Remote Patient Monitoring Market, By Value, in USD Billion, 2017-2031F
Figure 127. South Korea Remote Patient Monitoring Market, By Volume, in Million Units, 2017-2031F
Figure 128. South Korea Remote Patient Monitoring Market Share (%), By Product, 2017-2031F
Figure 129. South Korea Remote Patient Monitoring Market Share (%), By Application, 2017-2031F
Figure 130. South Korea Remote Patient Monitoring Market Share (%), By End-user, 2017-2031F
Figure 131. Indonesia Remote Patient Monitoring Market, By Value, in USD Billion, 2017-2031F
Figure 132. Indonesia Remote Patient Monitoring Market, By Volume, in Million Units, 2017-2031F
Figure 133. Indonesia Remote Patient Monitoring Market Share (%), By Product, 2017-2031F
Figure 134. Indonesia Remote Patient Monitoring Market Share (%), By Application, 2017-2031F
Figure 135. Indonesia Remote Patient Monitoring Market Share (%), By End-user, 2017-2031F
Figure 136. Philippines Remote Patient Monitoring Market, By Value, in USD Billion, 2017-2031F
Figure 137. Philippines Remote Patient Monitoring Market, By Volume, in Million Units, 2017-2031F
Figure 138. Philippines Remote Patient Monitoring Market Share (%), By Product, 2017-2031F
Figure 139. Philippines Remote Patient Monitoring Market Share (%), By Application, 2017-2031F
Figure 140. Philippines Remote Patient Monitoring Market Share (%), By End-user, 2017-2031F
Figure 141. Middle East & Africa Remote Patient Monitoring Market, By Value, in USD Billion, 2017-2031F
Figure 142. Middle East & Africa Remote Patient Monitoring Market, By Volume, in Million Units, 2017-2031F
Figure 143. Middle East & Africa Remote Patient Monitoring Market Share (%), By Product, 2017-2031F
Figure 144. Middle East & Africa Remote Patient Monitoring Market Share (%), By Application, 2017-2031F
Figure 145. Middle East & Africa Remote Patient Monitoring Market Share (%), By End-user, 2017-2031F
Figure 146. Middle East & Africa Remote Patient Monitoring Market Share (%), By Country, 2017-2031F
Figure 147. Saudi Arabia Remote Patient Monitoring Market, By Value, in USD Billion, 2017-2031F
Figure 148. Saudi Arabia Remote Patient Monitoring Market, By Volume, in Million Units, 2017-2031F
Figure 149. Saudi Arabia Remote Patient Monitoring Market Share (%), By Product, 2017-2031F
Figure 150. Saudi Arabia Remote Patient Monitoring Market Share (%), By Application, 2017-2031F
Figure 151. Saudi Arabia Remote Patient Monitoring Market Share (%), By End-user, 2017-2031F
Figure 152. UAE Remote Patient Monitoring Market, By Value, in USD Billion, 2017-2031F
Figure 153. UAE Remote Patient Monitoring Market, By Volume, in Million Units, 2017-2031F
Figure 154. UAE Remote Patient Monitoring Market Share (%), By Product, 2017-2031F
Figure 155. UAE Remote Patient Monitoring Market Share (%), By Application, 2017-2031F
Figure 156. UAE Remote Patient Monitoring Market Share (%), By End-user, 2017-2031F
Figure 157. South Africa Remote Patient Monitoring Market, By Value, in USD Billion, 2017-2031F
Figure 158. South Africa Remote Patient Monitoring Market, By Volume, in Million Units, 2017-2031F
Figure 159. South Africa Remote Patient Monitoring Market Share (%), By Product, 2017-2031F
Figure 160. South Africa Remote Patient Monitoring Market Share (%), By Application, 2017-2031F
Figure 161. South Africa Remote Patient Monitoring Market Share (%), By End-user, 2017-2031F
Figure 162. By Product Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 163. By Application Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 164. By End-user Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 165. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2023

Product Code: MX11074

Global remote patient monitoring market is projected to witness a CAGR of 13.26% during the forecast period 2024-2031, growing from USD 9.53 billion in 2023 to USD 25.8 billion in 2031. The market expansion is supported by the growing awareness about the various cost benefits associated with remote patient monitoring (RPM) and telehealth and rising investments towards RPM by various key players in the market. Remote patient monitoring systems and devices are often used to help patients who require post-discharge care or are suffering from chronic diseases. Using RPM solutions to monitor the health and vitals of high-risk patients allows organizations to stay updated with data between patient visits and notify them about any potential health issues. RPM devices enhance patient engagement, improve care, and allow patients to have better access to healthcare. Due to the growing awareness about the various advantages associated with the utilization of remote patient monitoring devices and services, several hospitals are adopting such systems, thereby acting as a major growth-inducing factor.

For instance, in 2023, AJ Hospital and Research Centre in Mangaluru adopted an AI-based continuous and contactless remote patient monitoring (RPM) and early warning system (EWS) created by Dozee on fifty beds in their private ward. The early warning system allows the tracking of vital parameters and ensures the provision of alerts to healthcare providers for timely medical intervention in case of patient's clinical deterioration.

Increasing Investments and Strategic Collaborations Support Market Growth

Rising investments by various hospitals and healthcare centers towards remote patient monitoring systems and software to enhance patient convenience and improve patient care is bolstering the remote patient monitoring market growth. In January 2024, a renowned multispecialty hospital in Bangalore, Apollo Hospital Seshadripuram, announced a partnership with an AI-powered health monitoring technology company called LifeSigns. The collaboration is expected to mark a significant advancement in proactive patient management and precision healthcare by empowering the hospital with a wireless remote patient monitoring system. The hospital's commitment to digital transformation will ensure the continuous integration of upgraded LifeSigns solutions in their core operations. They are also going to ensure that the systems are available to all their patients from now onwards. The system uses biosensors for continuously tracking vital signs, including SPO2, blood pressure, and ECG, among others. The secure transmission of real-time data to a platform accessible to healthcare professionals will facilitate continuous monitoring, allowing early identification of any potential complications.

Rising Prevalence of Chronic Diseases and Geriatric Population Boosts Market Expansion

The growing awareness about the various advantages associated with the adoption of remote patient monitoring for the management of chronic diseases is providing lucrative growth opportunities to the market. Various healthcare providers are leveraging remote patient monitoring to provide care for patients suffering from chronic diseases, including cancer, diabetes, cardiovascular diseases, and chronic lung diseases. RPM allows healthcare providers to collect relevant data, track patient health, and make necessary interventions to avoid adverse events. Remote patient management acts as a valuable tool for chronic disease management by tracking the vitals of the patients and alerting them and their caregivers and healthcare providers about necessary information. For instance, in diabetes, RPM tracks the blood sugar levels of the patient, along with physical activity and insulin intake. Remote patient monitoring aims to provide better care to patients by understanding their condition and closely tracking their progress. According to the World Health Organization (WHO), by around 2050, various chronic diseases, including diabetes, cardiovascular diseases, respiratory diseases, and cancer, will account for 86% of the 90 million deaths every year. The remote patient monitoring market demand is increasing due to the growing prevalence of such chronic diseases.

North America Accounts for a Significant Share of the Market

The expansion of the market in the region can be attributed to growing emphasis on the adoption of the Internet of Things (IoT) medical devices, rising investments in telehealth, and the strong presence of various market players. As per a Harvard Health Letter article published in December 2022, approximately 50 million individuals in the United States alone use remote patient monitoring devices. One of the first RPM devices to be adopted was home blood pressure machines. The increasing prevalence of heart diseases and strokes in the region is further bolstering the demand for remote patient monitoring devices. According to Centre for Disease Control and Prevention, over 877,500 Americans die from stroke and heart diseases, among other cardiovascular diseases every year. Heart disease is the leading cause of death in the United States, while stroke takes the fifth position among all deaths in the United States. Remote patient monitoring allows the utilization of electronic devices to record relevant data of a patient for review and evaluation later by their healthcare provider or physician.

For instance, a patient can use RPM devices for regular monitoring of their blood pressure and share the results with their regular physician. The increasing awareness about the various advantages associated with the utilization of RPM devices is supporting the growth of the North America remote patient monitoring market.

Special Monitors Anticipated to Witness Significant Growth in the Coming Years

The increase in utilization and demand of special monitors, such as blood glucose monitors, anesthesia monitors, and multi-parameter monitors, over the forecast period can be attributed to the growing requirement for monitoring clinically important and pre- and post-surgery data for identification of systems and prevention of complications.

For instance, regularly monitoring blood glucose levels is essential for patients with diabetes as they, at times, do not feel any symptoms that are associated with diabetes until the blood glucose levels become too high. The utilization of RPM devices for monitoring blood glucose levels allows practitioners to use the captured data for detecting potential alarming changes in the levels of glucose and take necessary actions immediately. Additionally, the collected data can also provide insights to practitioners that will aid them in recommending necessary alterations in exercise, medications, and diet. Remote patient monitoring also allows the effective mitigation of gestational diabetes. As per the Centre for Disease Control and Prevention, approximately 1-2% of pregnant women in the United States have either Type 1 or Type 2 diabetes and nearly 6-9% of women develop gestational diabetes during pregnancy.

Rising Utilization of RPM for Cardiovascular Diseases

The potential of remote patient monitoring in reducing the burden of managing and monitoring cardiovascular diseases is resulting in a burgeoning volume of research. The research activities aim to evaluate the economic and clinical effectiveness of RPM. According to an article published by American Heart Association, it is projected that by 2035, over 42% of adults in the United States will be hypertensive. The cost projections for hypertension are daunting, with 2035 figures to soar over USD 150 billion. Remote patient monitoring is expected to serve as a vital conduit for reducing the economic burden stemming from expensive hospital stays because of acute hypertension related events. Research has shown that remote patient monitoring can reduce diastolic blood pressure and systolic blood pressure significantly as compared to self-monitoring. Additional studies have shown that the positive impact of remote patient monitoring on systolic blood pressure can increase if the intervention includes multiple behavior change techniques and is long-term.

Future Market Scenario (2024 - 2031F)

The broader use of remote patient monitoring, guided with operational knowledge and high-quality research, is expected to support advancements in hospitals and at home models of care. It has significant potential to benefit from the value provided by healing in the comfort of home.

In February 2024, MD Revolution announced that their partner, Cardiac Solutions, achieved a 50% reduction in the rate of hospital cardiovascular readmission by using chronic care management and RevUp Remote Patient Monitoring as part of their program. The conducted study showed sustained benefits on an annual basis and demonstrated high cost-saving potential and efficacy.

Key Players Landscape and Outlook

Key participants in the remote patient monitoring market include OMRON Corporation, Koninklijke Philips N.V., F. Hoffmann-La Roche AG, GE Healthcare, and Abbott Laboratories. In 2023, OMRON Healthcare India announced collaboration with Tricog, a Bengaluru-based firm. This collaboration is expected to be OMRON's foray into remote heart management and monitoring segment.

In May 2023, Abbott received U.S. Food and Drug Administration (FDA) clearance for their Assert-IQ insertable cardiac monitor (ICM). This clearance expands the company's portfolio of connected health devices that can aid doctors in treating their patients remotely.

1. Research Methodology

2. Project Scope & Definitions

3. Executive Summary

4. Global Remote Patient Monitoring Market Outlook, 2017-2031F

4.1. Market Size & Forecast
- 4.1.1. By Value
- 4.1.2. By Volume
4.2. By Product
- 4.2.1. Special Monitor
  - 4.2.1.1. Blood Glucose Monitors
  - 4.2.1.2. Anesthesia Monitors
  - 4.2.1.3. Multi-Parameter Monitors
  - 4.2.1.4. Others
- 4.2.2. Vital Sign Monitor
  - 4.2.2.1. Temperature Monitors
  - 4.2.2.2. Blood Pressure Monitors
  - 4.2.2.3. Respiratory Rate Monitors
  - 4.2.2.4. Others
- 4.2.3. Software
- 4.2.4. Services
4.3. By Application
- 4.3.1. Cardiovascular Diseases
- 4.3.2. Weight Management and Fitness Monitoring
- 4.3.3. Sleep Disorder
- 4.3.4. Infections
- 4.3.5. Cancer
- 4.3.6. Dehydration
- 4.3.7. Hypertension
- 4.3.8. Others
4.4. By End-user
- 4.4.1. Ambulatory Patients
- 4.4.2. Home Healthcare
- 4.4.3. Hospital-Based Patients
- 4.4.4. Others
4.5. By Region
- 4.5.1. North America
- 4.5.2. South America
- 4.5.3. Europe
- 4.5.4. Asia-Pacific
- 4.5.5. Middle East & Africa
4.6. By Company Market Share (%), 2023

5. Global Remote Patient Monitoring Market Outlook, By Region, 2017-2031F

5.1. North America*
- 5.1.1. Market Size & Forecast
  - 5.1.1.1. By Value
  - 5.1.1.2. By Volume
- 5.1.2. By Product
  - 5.1.2.1. Special Monitors
  - 5.1.2.1.1. Blood Glucose Monitors
  - 5.1.2.1.2. Anesthesia Monitors
  - 5.1.2.1.3. Multi-Parameter Monitors
  - 5.1.2.1.4. Others
  - 5.1.2.2. Vital Sign Monitors
  - 5.1.2.2.1. Temperature Monitors
  - 5.1.2.2.2. Blood Pressure Monitors
  - 5.1.2.2.3. Respiratory Rate Monitors
  - 5.1.2.2.4. Others
  - 5.1.2.3. Software
  - 5.1.2.4. Services
- 5.1.3. By Application
  - 5.1.3.1. Cardiovascular Diseases
  - 5.1.3.2. Weight Management and Fitness Monitoring
  - 5.1.3.3. Sleep Disorder
  - 5.1.3.4. Infections
  - 5.1.3.5. Cancer
  - 5.1.3.6. Dehydration
  - 5.1.3.7. Hypertension
  - 5.1.3.8. Others
- 5.1.4. By End-user
  - 5.1.4.1. Ambulatory Patients
  - 5.1.4.2. Home Healthcare
  - 5.1.4.3. Hospital-Based Patients
  - 5.1.4.4. Others
- 5.1.5. United States*
  - 5.1.5.1. Market Size & Forecast
  - 5.1.5.1.1. By Value
  - 5.1.5.1.2. By Volume
  - 5.1.5.2. By Product
  - 5.1.5.2.1. Special Monitors
  - 5.1.5.2.1.1. Blood Glucose Monitors
  - 5.1.5.2.1.2. Anesthesia Monitors
  - 5.1.5.2.1.3. Multi-Parameter Monitors
  - 5.1.5.2.1.4. Others
  - 5.1.5.2.2. Vital Sign Monitors
  - 5.1.5.2.2.1. Temperature Monitors
  - 5.1.5.2.2.2. Blood Pressure Monitors
  - 5.1.5.2.2.3. Respiratory Rate Monitor
  - 5.1.5.2.2.4. Others
  - 5.1.5.2.3. Software
  - 5.1.5.2.4. Services
  - 5.1.5.3. By Application
  - 5.1.5.3.1. Cardiovascular Diseases
  - 5.1.5.3.2. Weight Management and Fitness Monitoring
  - 5.1.5.3.3. Sleep Disorder
  - 5.1.5.3.4. Infections
  - 5.1.5.3.5. Cancer
  - 5.1.5.3.6. Dehydration
  - 5.1.5.3.7. Hypertension
  - 5.1.5.3.8. Others
  - 5.1.5.4. By End-user
  - 5.1.5.4.1. Ambulatory Patients
  - 5.1.5.4.2. Home Healthcare
  - 5.1.5.4.3. Hospital-Based Patients
  - 5.1.5.4.4. Others
- 5.1.6. Canada
- 5.1.7. Mexico

All segments will be provided for all regions and countries covered

5.2. Europe
- 5.2.1. Germany
- 5.2.2. France
- 5.2.3. Italy
- 5.2.4. United Kingdom
- 5.2.5. Russia
- 5.2.6. Netherlands
- 5.2.7. Spain
- 5.2.8. Turkey
- 5.2.9. Poland
5.3. Asia-Pacific
- 5.3.1. India
- 5.3.2. China
- 5.3.3. Japan
- 5.3.4. Australia
- 5.3.5. Vietnam
- 5.3.6. South Korea
- 5.3.7. Indonesia
- 5.3.8. Philippines
5.4. South America
- 5.4.1. Brazil
- 5.4.2. Argentina
5.5. Middle East & Africa
- 5.5.1. Saudi Arabia
- 5.5.2. UAE
- 5.5.3. South Africa

6. Market Mapping, 2023

6.1. By Product
6.2. By Application
6.3. By End-user
6.4. By Region

7. Macro Environment and Industry Structure

7.1. Supply Demand Analysis
7.2. Import Export Analysis
7.3. Value Chain Analysis
7.4. PESTEL Analysis
- 7.4.1. Political Factors
- 7.4.2. Economic System
- 7.4.3. Social Implications
- 7.4.4. Technological Advancements
- 7.4.5. Environmental Impacts
- 7.4.6. Legal Compliances and Regulatory Policies (Statutory Bodies Included)
7.5. Porter's Five Forces Analysis
- 7.5.1. Supplier Power
- 7.5.2. Buyer Power
- 7.5.3. Substitution Threat
- 7.5.4. Threat from New Entrant
- 7.5.5. Competitive Rivalry

8. Market Dynamics

8.1. Growth Drivers
8.2. Growth Inhibitors (Challenges and Restraints)

9. Regulatory Framework and Innovation

9.1. Patent Landscape
9.2. Regulatory Approvals
9.3. Innovations/Emerging Technologies

10. Key Players Landscape

10.1. Competition Matrix of Top Five Market Leaders
10.2. Market Revenue Analysis of Top Five Market Leaders (in %, 2023)
10.3. Mergers and Acquisitions/Joint Ventures (If Applicable)
10.4. SWOT Analysis (For Five Market Players)
10.5. Patent Analysis (If Applicable)

11. Pricing Analysis

12. Case Studies

13. Key Players Outlook

13.1. Abbott Laboratories
- 13.1.1. Company Details
- 13.1.2. Key Management Personnel
- 13.1.3. Products & Services
- 13.1.4. Financials (As reported)
- 13.1.5. Key Market Focus & Geographical Presence
- 13.1.6. Recent Developments
13.2. OMRON Corporation
13.3. Koninklijke Philips N.V.
13.4. F. Hoffmann-La Roche AG
13.5. GE Healthcare
13.6. Boston Scientific Corporation
13.7. Nihon Kohden Corporation
13.8. Johnson & Johnson
13.9. BIOTRINIK SE & Co.
13.10. MD Revolution

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work

遠隔患者モニタリング (RPM) の世界市場の評価：製品別、用途別、エンドユーザー別、地域別、機会、予測（2017年～2031年）

Remote Patient Monitoring Market Assessment, By Product, By Application, By End-user, By Region, Opportunities and Forecast, 2017-2031F

目次

第1章調査手法

第2章プロジェクトの範囲と定義

第3章エグゼクティブサマリー

第4章世界の遠隔患者モニタリング (RPM) 市場の展望

第5章世界の遠隔患者モニタリング (RPM) 市場の展望：地域別

第6章市場マッピング

第7章マクロ環境と産業構造

第8章市場力学

第9章法規制の枠組み・イノベーション

第10章主要企業の情勢

第11章価格分析

第12章ケーススタディ

第13章主要企業の見通し

第14章戦略的提言

第15章当社について・免責事項

List of Tables

List of Figures

Table of Contents

1. Research Methodology

2. Project Scope & Definitions

3. Executive Summary

4. Global Remote Patient Monitoring Market Outlook, 2017-2031F

5. Global Remote Patient Monitoring Market Outlook, By Region, 2017-2031F

6. Market Mapping, 2023

7. Macro Environment and Industry Structure

8. Market Dynamics

9. Regulatory Framework and Innovation

10. Key Players Landscape

11. Pricing Analysis

12. Case Studies

13. Key Players Outlook

14. Strategic Recommendations

15. About Us & Disclaimer

遠隔患者モニタリング (RPM) の世界市場の評価：製品別、用途別、エンドユーザー別、地域別、機会、予測（2017年～2031年）

Remote Patient Monitoring Market Assessment, By Product, By Application, By End-user, By Region, Opportunities and Forecast, 2017-2031F

目次

第1章 調査手法

第2章 プロジェクトの範囲と定義

第3章 エグゼクティブサマリー

第4章 世界の遠隔患者モニタリング (RPM) 市場の展望

第5章 世界の遠隔患者モニタリング (RPM) 市場の展望：地域別

第6章 市場マッピング

第7章 マクロ環境と産業構造

第8章 市場力学

第9章 法規制の枠組み・イノベーション

第10章 主要企業の情勢

第11章 価格分析

第12章 ケーススタディ

第13章 主要企業の見通し

第14章 戦略的提言

第15章 当社について・免責事項

List of Tables

List of Figures

Table of Contents

1. Research Methodology

2. Project Scope & Definitions

3. Executive Summary

4. Global Remote Patient Monitoring Market Outlook, 2017-2031F

5. Global Remote Patient Monitoring Market Outlook, By Region, 2017-2031F

6. Market Mapping, 2023

7. Macro Environment and Industry Structure

8. Market Dynamics

9. Regulatory Framework and Innovation

10. Key Players Landscape

11. Pricing Analysis

12. Case Studies

13. Key Players Outlook

14. Strategic Recommendations

15. About Us & Disclaimer

第1章調査手法

第2章プロジェクトの範囲と定義

第3章エグゼクティブサマリー

第4章世界の遠隔患者モニタリング (RPM) 市場の展望

第5章世界の遠隔患者モニタリング (RPM) 市場の展望：地域別

第6章市場マッピング

第7章マクロ環境と産業構造

第8章市場力学

第9章法規制の枠組み・イノベーション

第10章主要企業の情勢

第11章価格分析

第12章ケーススタディ

第13章主要企業の見通し

第14章戦略的提言

第15章当社について・免責事項